Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain

European Journal of Neuroscience

Volumn 19, Issue 7, 2004, Pages 1826-1836

  Valjent, Emmanuel ^a   Pagès, Christiane ^b   Hervé, Denis ^a   Girault, Jean Antoine ^a   Caboche, Jocelyne ^b  

^a INSTITUT DU FER À MOULIN   (France)

^b CNRS   (France)

Author keywords

CD 1 mice; D1 receptors; Dopamine; Drug of abuse; Extended amygdala; Nucleus accumbens

Indexed keywords

ANTIDEPRESSANT AGENT; CAFFEINE; COCAINE; DRONABINOL; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; NEUROLEPTIC AGENT; NICOTINE; SCOPOLAMINE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE; ENZYME ACTIVATION; HIPPOCAMPUS; IMMUNOCYTOTOXICITY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; STRIA TERMINALIS;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADRENERGIC UPTAKE INHIBITORS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BRAIN; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DESIPRAMINE; DOPAMINE ANTAGONISTS; ENZYME ACTIVATION; FLUOXETINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; MUSCARINIC ANTAGONISTS; NEURONS; NICOTINE; NICOTINIC AGONISTS; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITORS; TETRAHYDROCANNABINOL;

EID: 1842784821     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03278.x     Document Type: Article

References (73)

1. Alheid, G.F. & Heimer, L. (1988) New perspectives in basal forebrain organization of special relevance for neuropsychiatrie disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience, 27, 1-39.
2. Allen, K.V., McGregor, I.S., Hunt, G.E., Singh, M.E. & Mallet, P.E. (2003) Regional differences in naloxone modulation of Delta (9)-THC induced Fos expression in rat brain. Neuropharmacology, 44, 264-274.
3. Amara, S.G. & Kuhar, M.J. (1993) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci., 16, 73-93.
4. Barbara, J.G., Auclair, N., Roisin, M.P., Otani, S., Valjent, E., Caboche, J., Soubrie, P. & Crepel, F. (2003) Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex. Eur. J. Neurosci., 17, 981-990.
5. Bedingfield, J.B., King, D.A. & Holloway, P.A. (1998) Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol. Biochem. Behav., 61, 291-296.
6. Bergqvist, P.B., Dong, J. & Blier, P. (1999) Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electro-physiological study. Psychopharmacology, 143, 89-96.
7. Berke, J.D. & Hyman, S.E. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron, 25, 515-532.
8. Carboni, E., Silvagni, A., Rolando, M.T. & Di Chiara, G. (2000) Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J. Neurosci., 20, RC102.
9. Choe, E.S., Chung, K.T., Mao, L. & Wang, J.Q. (2002) Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology, 27, 565-575.
10. Choe, E.S. & Wang, J.Q. (2002) CaMKJI regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons. Neuroreport, 13, 1013-1016.
11. Curran, H.V., Brignell, C., Fletcher, S., Middleton, P. & Henry, J. (2002) Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Bert.), 164, 61-70.
12. Daly, J.W. & Fredholm, B.B. (1998) Caffeine - an atypical drug of dependence. Drug Alcohol Depend., 51, 199-206.
13. Dani, J.A., Ji, D. & Zhou, F.M. (2001) Synaptic plasticity and nicotine addiction. Neuron, 31, 349-352.
14. David, D.J., Renard, C.E., Jolliet, P., Hascoet, M. & Bourin, M. (2003) Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl.), 166, 373-382.
15. Dawson, T.M., Barone, P., Sidhu, A., Wamsley, J.K. & Chase, T.N. (1988) The Dl dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience, 26, 83-100.
16. De Angelis, I (1996) Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fiuoxetine and imipramine in mice. Naunyn Schmiedebergs Arch. Pharmacol., 354, 379-383.
17. Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J. &Girault, J.A. (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci., 23, 2371-2382.
18. Di Chiara, G. (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol., 375, 13-30.
19. Di Chiara, G. & Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA, 85, 5274-5278.
20. Eitan, S., Bryant, C.D., Saliminejad, N., Yang, Y.C., Vojdani, E., Keith, D. Jr, Polakiewicz, R. & Evans, C.J. (2003) Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J. Neurosci., 23, 8360-8369.
21. El Yacoubi, M., Ledent, C., Menard, J.F., Parmentier, M., Costentin, J. & Vaugeois, J.M. (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A (2A) receptors. Br. J. Pharmacol., 129, 1465-1473.
22. Everitt, B.J. &Wolf, M.E. (2002) Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci., 22, 3312-3320.
23. Frazer, A. (2000) Norepinephrine involvement in antidepressant action. J. Clin. Psychiatry, 61, 25-30.
24. Fremeau, R.T., Duncan, G.E., Fornaretto, M.G., dearry, A., Gingrich, J.A., Breese, G.R. &Caron, M.G. (1991) Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl Acad. Sci. USA, 88, 3772-3776.
25. Heimer, L. & Alheid, G.F. (1991) Piecing together the puzzle of basal forebrain anatomy. Adv. Exp. Med. Biol., 295, 1-42.
26. Hyman, S.E. & Malenka, R.C. (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Rev. Neurosci., 2, 695-703.
27. Jamshidi, N. & Taylor, D.A. (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol., 134, 1151-1154.
28. Jones, S., Kornblum, J.L. & Kauer, J.A. (2000) Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J. Neurosci., 20, 5575-5580.
29. Kieffer, B.L. (1999) Opioids: first lessons from knockout mice. TIPS, 20, 19-26.
30. Kombian, S.B. & Malenka, R.C. (1994) Simultaneous LTP of non-NMDA-and LTD of NMDA-receptor-mediated responses in the nucleus accumbens. Nature, 368, 242-246.
31. Koob, G.F. & Le Moal, M. (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97-129.
32. Koob, G.F., Sanna, P.P. & Bloom, F.E. (1998) Neuroscience of addiction. Neuron, 21, 467-476.
33. Kuoppamaki, M., Syvalahti, E. & Hietala, J. (1993) Clozapine and N-desmethylclozapine are potent 5-HT1Creceptor antagonists. Eur. J. Pharmacol., 245, 179-182.
34. Le Fur, G., Burgevin, M.C., Malgouris, C. & Uzan, A. (1979) Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors. Neuropharmacology, 18, 591-594.
35. Ledent, C., Vaugeois, J.M., Schiffmann, S.N., Pedrazzini, T., El Yacoubi, M., Vanderhaeghen, J.J., Costentin, J., Heath, J.K., Vassart, G. & Parmentier, M. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature, 388, 674-678.
36. 2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity. Psychopharmacology, 112, 389-397.
37. Maldonado, R. & Rodriguez de Fonseca, F. (2002) Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci., 22, 3326-3331.
38. Mansour, A., Meador-Woodruff, J.H., Zhou, Q.Y., Civelli, O., Akil, H. & Watson, S.J. (1991) A comparison of D1 receptor binding and mRNA in rat brain using autoradiographic and in situ hybridization techniques. Neuroscience, 45, 359-371.
39. Mansvelder, H.D. & McGehee, D.S. (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 27, 349-357.
40. Martin, M., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2000) Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur. J. Neurosci., 12, 4038-4046.
41. Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D.P., Pages, G., Valverde, O., Marowsky, A., Porrazzo, A., Orban, P.C., Maldonado, R., Ehrengruber, M.U., Cestari, V., Lipp, H.P., Chapman, P.P., Pouyssegur, J. & Brambilla, R. (2002) Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron, 34, 807-820.
42. Moratalla, R., Xu, M., Tonegawa, S. & Graybiel, A.M. (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl Acad. Sci. USA., 93, 14928-14933.
43. Mueller, K. & Peel, J.L. (1990) Scopolamine produces locomotor stereotypy in an open field but apomorphine does not. Pharmacol. Biochem. Behav., 36, 613-617.
44. Nestler, E.J. (2001) Molecular basis of long-term plasticity underlying addiction. Nature Rev. Neurosci., 2, 119-128.
45. Ouagazzal, A.M., Kenny, P.J. & File, S.E. (1999) Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur. J. Neurosci., 11, 3957-3962.
46. Owens, M.J., Morgan, W.N., Plott, S.J. & Nemeroff, C.B. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther., 283, 1305-1322.
47. Patkina, N.A. & Zvartau, E.E. (1998) Caffeine place conditioning in rats: comparison with cocaine and ethanol. Eur. Neuropsychopharmacol., 8, 287-291.
48. Paxinos, G. & Franklin, K.B.J. (2001) The Mouse Brain in Stereotaxic Coordinates, Edn. 2.Academic Press.
49. Pierce, R.C., Pierce-Bancroft, A.F. & Prasad, B.M. (1999) Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J. Neurosci., 19, 8685-8695.
50. Pozzi, L., Hakansson, K., Usiello, A., Borgkvist, A., Lindskog, M., Greengard, P. & Fisone, G. (2003) Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J. Neurochem., 86, 451-459.
51. Reynolds, J.N., Hyland, B.I. & Wickens, J.R. (2001) A cellular mechanism of reward-related learning. Nature, 413, 67-70.
52. Reynolds, J.N. & Wickens, J.R. (2002) Dopamine-dependent plasticity of corticostriatal synapses. Neural Networks, 15, 507-521.
53. Saal, D., Dong, Y., Bonci, A. & Malenka, R.C. (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron, 37, 577-582.
54. Salzmann, J., Marie-Claire, C., Le Guen, S., Roques, B.P. & Noble, F. (2003) Importance of ERK activation in behavioural and biochemical effects induced by MDMA in mice. Br. J. Pharmacol., 140, 831-838.
55. Schultz, W. (1997) Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol., 7, 191-197.
56. Schultz, W. (2002) Getting formal with dopamine and reward. Neuron, 36, 241-263.
57. Schulz, S. & Hollt, V. (1998) Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur. J. Neurosci., 10, 1196-1201.
58. Shaw-Lutchman, T.Z., Barrot, M., Wallace, T., Gilden, L., Zachariou, V., Impey, S., Duman, R.S., Storm, D. & Nestler, E.J. (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrex-one-precipitated morphine withdrawal. J. Neurosci., 22, 3663-3672.
59. Shaw-Lutchman, T.Z., Impey, S., Storm, D. & Nestler, E.J. (2003) Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse, 48, 10-17.
60. Smythe, J.W., Murphy, D., Bhatnagar, S., Timothy, C. & Costall, B. (1996) Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacol. Biochem. Behav., 54, 57-63.
61. Thomas, M.J., Beurrier, C., Bonci, A. & Malenka, R.C. (2001) Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nature Neurosci., 4, 1217-1223.
62. Thomas, M.J., Malenka, R.C. & Bonci, A. (2000) Modulation of long-term depression by dopamine in the mesolimbic system. J. Neurosci., 20, 5581-5586.
63. Ungless, M.A., Whistler, J.L., Malenka, R.C. & Bonci, A. (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature, 411, 583-587.
64. Valjent, E., Caboche, J. & Vanhoutte, P. (2001a) Mitogen-activated protein kinase/extracellular signal-regulated kinase induced gene regulation in brain: a molecular substrate for learning and memory? Mol. Neurobiol., 23, 83-99.
65. Valjent, E., Corvol, J.C., Pages, C., Besson, M.J., Maldonado, R. & Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci., 20, 8701-8709.
66. Valjent, E., Hervé, D., Caboche, J. & Girault, J.A. (2003) Possible role of the extracellular signal-regulated kinase (ERK) in reward-controlled learning and addiction. Curr. Neuropharmacol., 1, 165-174.
67. Valjent, E. & Maldonado, R. (2000) A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl.), 147, 436-438.
68. Valjent, E., Pages, C., Rogard, M., Besson, M.J., Maldonado, R. & Caboche, J. (2001b) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci., 14, 342-352.
69. Van Tol, H.H., Bunzow, J.R., Guan, H.C., Sunahara, R.K., Seeman, P., Niznik, H.B. & Civelli, O. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610-614.
70. Vanderschuren, L.J., De Vries, T.J., Wardeh, G., Hogenboom, F.A. & Schoffelmeer, A.N. (2001) Eur. J. Neurosci., 14, 1533-1538.
71. Vanderschuren, L.J., Schimdt, E.D., De Vries, T.J., Van Moorsel, C.A., Tilders, F.J. & Schoffelmeer, A.N. (1999) A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J. Neurosci., 19, 9579-9586.
72. Wise, R.A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol., 6, 243-251.
73. Wise, R.A. (2002) Brain reward circuitry: insights from unsensed incentives. Neuron, 36, 229-240.